Cyntellect Gets CE Mark for LEAP, Ships System to Undisclosed European Pharma | GenomeWeb
NEW YORK (GenomeWeb News) – Cyntellect said today that it has gained the European Union’s CE mark for its Laser-Enabled Analysis and Processing system.
 
The company said that it has also shipped a LEAP system to “a major pharmaceutical company customer in Europe,” marking the first commercial delivery of the system to the EU.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.